4886

ASKA Pharmaceutical Holdings CO., Ltd.

あすか製薬ホールディングス株式会社
Pharmaceutical
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.
← Companies
Price
¥2,930
Market Cap
¥83.1B
Ent. Value
¥84.4B
Net Debt
−¥1.3B
Shares Out.
28.4M
P / E
15.3×
EV / EBIT
14.5×
P / Book
1.19×
P / NCAV
3.21×
Div. Yield
0.92%
Financials
Metric FY 2025
TDnet 		FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗ 		FY 2021
EDINET ↗
Net Sales ¥71.1B ¥64.1B ¥62.8B ¥60.5B ¥56.6B
Cost of Sales ¥37.0B ¥32.8B ¥32.2B ¥31.9B ¥30.3B
Gross Profit ¥34.1B ¥31.3B ¥30.7B ¥28.6B ¥26.4B
SG&A ¥28.3B ¥26.0B ¥24.2B ¥23.5B ¥21.6B
Operating Income ¥5.8B ¥5.3B ¥6.5B ¥5.1B ¥4.8B
Non-Operating Income ¥740M ¥398M ¥414M ¥433M ¥379M
Dividend Income — ¥286M ¥330M ¥338M ¥258M
Interest Income — ¥6M ¥4M ¥0M ¥0M
Non-Operating Expenses — ¥622M ¥392M ¥308M ¥294M
Interest Expense — ¥51M ¥40M ¥50M ¥56M
Ordinary Income ¥5.7B ¥5.1B ¥6.5B ¥5.2B ¥4.9B
Pre-tax Income ¥7.0B ¥6.2B ¥9.9B ¥5.4B ¥6.2B
Income Taxes ¥1.4B ¥1.1B ¥2.3B ¥1.1B ¥1.9B
Current Tax — ¥750M ¥3.5B ¥1.1B ¥983M
Deferred Tax — ¥341M ¥-1.2B ¥10M ¥890M
Net Income (owners) ¥5.4B ¥5.1B ¥7.5B ¥4.2B ¥4.3B
Comprehensive Income — ¥5.2B ¥8.1B ¥6.0B ¥5.0B
EBITDA ¥8.8B ¥7.6B ¥9.2B ¥8.2B ¥7.7B
EPS ¥191.12 ¥179.95 ¥266.51 ¥150.08 ¥151.22
Shares Outstanding — 28.4M 28.3M 28.3M 28.2M
Shares Issued (total) — 28.8M 30.6M 30.6M 30.6M
Treasury Shares — 0.4M 2.2M 2.3M 2.3M